Wolverine Blend – BPC-157 (10mg) / TB500 (10mg) Peptide blend

Description

A single-component research material supplied for controlled research environments. Suitable for studies involving GHRH-receptor pathway characterization and method development in model systems.

Composition

• BPC-157: 10 mg

• TB-500 (Thymosin Beta 4): 10 mg

• Appearance: lyophilized powder in a sealed research vial

Wolverine Blend – BPC-157 (10mg) / TB500 (10mg)

Research Focus (non-clinical)

• Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems

• Assay development, including chromatographic separation of two co-formulated peptides

• Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions

• Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• Lot-specific COA available (HPLC/LC-MS)

• Batch and lot traceability

Important Notice

• For research use only

• Not for human consumption

• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Lot-specific COA (HPLC/LC-MS) with verification key

• Third-party verification link provided per lot (Janoshik)

• Lyophilized for transit stability; batch traceable

• Tamper-evident seal; lot & test date on each vial